Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Related Issuers

PX TALK/UPSIZE: Avantor Funding E650m 5NC2 1st lien 2.75% area

HYC US Market: Deal Flow - GeneralHYC European Market: Deal Flow - General

Avantor Funding Inc (AVTR) EUR650m (up from EUR550m) 144A/Reg S sr 1st lien notes due 2025 (5y). NC2 (MWC B+50bp) (50%, 25%, par). Equity claw: 2y 40%. B1/BB-/BB- (positive/positive/stable). Via GS/Citi joint active books/Barc/JPM/BofA joint books, PNC, HSBC, Jefferies as co-managers. No reg rights. List ISE. IPT mid 2s. The proceeds from the EUR100m (approx $117m) upsize and a $57m (approx EUR49) increase in its A/R facility draw will be used to reduce the size of the new term loan B.

Px talk: 2.75% area.

Did global investor call at 11am UKT, 7am NYT yesterday. Books close at 1pm UKT today. Pricing today UK afternoon. UOP: along with a $1.175bn (down from $1.35bn) term loan B via GS/Citi (did a lender call on 10/23, commitments due Fri), a $97m (up from $40m) draw on its A/R facility and $175m cash on hand, to redeem all of its $1.5bn 6% sr sec 1st lien notes due 10/01/24 (callable at 104.50) and all of its EUR500m 4.75% sr sec 1st lien notes due 10/01/24 (callable at 103.563). Biz: a global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, HQ: Radnor, PA.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.